Answer: Our required probability is 0.3162.
Step-by-step explanation:
Since we have given that
n = 60
Probability of success = 
Probability that at most 39 of these relays come from supplier A would be
Hence, our required probability is 0.3162.
Answer:
(1)
(2)
If we divide equations (2) and (1) we got:
And then 
And then we can find the value 
and we got from equation (1)
And then the general term for the sequence would be given by:
And the best option would be:
C) a1=759,375; an=an−1⋅(1/15)
Step-by-step explanation:
the general formula for a geometric sequence is given by:
For this case we know that 
Then we have the following conditions:
(1)
(2)
If we divide equations (2) and (1) we got:
And then
And then we can find the value and we got from equation (1)
And then the general term for the sequence would be given by:
And the best option would be:
C) a1=759,375; an=an−1⋅(1/15)
Answer:
0.09
Step-by-step explanation:
0.03 divided by 100
In this study, we tested the effects of NEAA-deprived diets and checkpoint inhibitor anti-PD-1 and anti-PD-L1 in colon cancer using syngeneic mouse model (Balb/c) bearing tumors of mouse colorectal cancer cell line CT-26. Three diets were tested, including a natural rodent diet Teklad ENVIGO Global 16% Protein Rodent Diet (control 1), a formulated NEAA-complete diet COMPLETE (control 2, using amino acid mix in place of protein), and a formulated NEAA-deprived diet FTN203 (treatment, using amino acid mix in place of protein). Both COMPLETE and FTN203 have the same nutritional structures, contain 17% w/w protein equivalent, and are isocaloric. After tumor size-based randomization, these diets were provided to mice ad libitum throughout the whole test. Each of these diets was used alone or combined with anti-PD-1 antibody (i.p., twice per week for 2 weeks) or anti-PD-L1 antibody (i.v., twice per week for 2 weeks).In this study, we tested the effects of NEAA-deprived diets and checkpoint inhibitor anti-PD-1 and anti-PD-L1 in colon cancer using syngeneic mouse model (Balb/c) bearing tumors of mouse colorectal cancer cell line CT-26. Three diets were tested, including a natural rodent diet Teklad ENVIGO Global 16% Protein Rodent Diet (control 1), a formulated NEAA-complete diet COMPLETE (control 2, using amino acid mix in place of protein), and a formulated NEAA-deprived diet FTN203 (treatment, using amino acid mix in place of protein). Both COMPLETE and FTN203 have the same nutritional structures, contain 17% w/w protein equivalent, and are isocaloric. After tumor size-based randomization, these diets were provided to mice ad libitum throughout the whole test. Each of these diets was used alone or combined with anti-PD-1 antibody (i.p., twice per week for 2 weeks) or anti-PD-L1 antibody (i.v., twice per week for 2 weeks).
